| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 05/17/2023 | CorMedix Inc. | CRMD | Purchase | Common Stock | 10k | $4.37 | $43.7k | | 05/17/2023 |
| 05/17/2023 | CorMedix Inc. | CRMD | Grant | Common Stock | 10k | $4.37 | $43.7k | | 05/17/2023 |
| 05/07/2019 | Amneal Pharmaceuticals, Inc. | AMRX | Payment of Exercise | Class A Common Stock | 21.6k | $13.44 | $290.4k | | 05/07/2019 |
| 05/07/2019 | Amneal Pharmaceuticals, Inc. | AMRX | Exercise | Restricted Stock Units | 83.3k | $0.00 | $0 | | 05/07/2019 |
| 03/12/2019 | Amneal Pharmaceuticals, Inc. | AMRX | Purchase | Class A Common Stock | 17k | $11.92 | $202.6k | | 03/12/2019 |
| 03/01/2019 | Amneal Pharmaceuticals, Inc. | AMRX | Grant | Restricted Stock Units | 197.5k | $0.00 | $0 | | 03/01/2019 |
| 03/01/2019 | Amneal Pharmaceuticals, Inc. | AMRX | Grant | Stock Option | 402.2k | $13.50 | $5.4M | | 03/01/2019 |
| 05/07/2018 | Amneal Pharmaceuticals, Inc. | AMRX | Grant | Restricted Stock Units | 333.1k | $0.00 | $0 | | 05/07/2018 |
| 05/07/2018 | Amneal Pharmaceuticals, Inc. | AMRX | Grant | Stock Option | 681.2k | $15.01 | $10.2M | | 05/07/2018 |
| 12/29/2017 | Allergan plc | AGN | Payment of Exercise | Ordinary Shares, par value $0.0001 | 2.1k | $163.58 | $351.5k | | 12/29/2017 |
| 10/26/2017 | Allergan plc | AGN | Exercise | Performance Based Restricted Share Unit | 12.4k | $0.00 | $0 | | 10/26/2017 |
| 04/03/2017 | Allergan plc | AGN | Grant | Ordinary Shares, par value $0.0001 | 7.4k | $237.68 | $1.7M | | 04/03/2017 |
| 03/05/2017 | Allergan plc | AGN | Payment of Exercise | Ordinary Shares, par value $0.0001 | 761 | $245.63 | $186.9k | | 03/05/2017 |
| 02/01/2017 | Allergan plc | AGN | Payment of Exercise | Ordinary Shares, par value $0.0001 | 798 | $229.32 | $183k | | 02/01/2017 |
| 02/01/2017 | Allergan plc | AGN | Conversion | Ordinary Shares, par value $0.0001 | 2.4k | $229.32 | $543.3k | | 02/01/2017 |
| 02/01/2017 | Allergan plc | AGN | Grant | Ordinary Shares, par value $0.0001 | 2.4k | $229.32 | $543.3k | | 02/01/2017 |
| 03/05/2015 | Allergan plc | AGN | Payment of Exercise | Ordinary Shares, par value $0.0001 | 593 | $295.70 | $175.4k | | 03/05/2015 |
| 03/05/2015 | Allergan plc | AGN | Grant | Ordinary Shares, par value $0.0001 | 4.6k | $0.00 | $0 | | 03/05/2015 |
| 03/05/2015 | Allergan plc | AGN | Payment of Exercise | Ordinary Shares, par value $0.0001 | 411 | $295.70 | $121.5k | | 03/05/2015 |
| 07/01/2014 | Allergan plc | AGN | Grant | Performance-Based Restricted Stock Unit | 28.2k | $0.00 | $0 | | 07/01/2014 |
| 07/01/2014 | Allergan plc | AGN | Grant | Stock Option (Right to Buy) | 25.7k | $224.00 | $5.8M | | 07/01/2014 |
| 05/09/2014 | Allergan plc | AGN | Grant | Ordinary Shares, par value $0.0001 | 3.4k | $197.05 | $666.6k | | 05/09/2014 |
| 12/09/2013 | Allergan plc | AGN | Sale | Ordinary Shares | 8k | $166.02 | $1.3M | | 12/09/2013 |
| 11/15/2013 | Allergan plc | AGN | Sale | Ordinary Shares | 10k | $164.44 | $1.6M | | 11/15/2013 |
| 11/11/2013 | Allergan plc | AGN | Sale | Ordinary Shares | 12k | $158.39 | $1.9M | | 11/11/2013 |
| 10/01/2013 | Allergan plc | AGN | Grant | Ordinary Shares | 71.3k | $0.00 | $0 | | 10/01/2013 |
| 08/02/2013 | Actavis, Inc. | ACT | Payment of Exercise | Common Stock, par value $0.0033 | 14.6k | $136.02 | $2M | | 08/02/2013 |
| 11/16/2009 | Actavis, Inc. | ACT | Grant | | 22k | $0.00 | $0 | | 11/16/2009 |